|
RANBP6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.19009999025133E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.44629996657164E-09 |
| Normal-vs-Stage2 |
1.185200E-01 |
| Normal-vs-Stage3 |
1.08669995224631E-09 |
| Normal-vs-Stage4 |
1.522720E-03 |
| Stage1-vs-Stage2 |
1.623240E-01 |
| Stage1-vs-Stage3 |
5.186300E-02 |
| Stage1-vs-Stage4 |
2.825600E-01 |
| Stage2-vs-Stage3 |
4.608200E-02 |
| Stage2-vs-Stage4 |
1.309000E-01 |
| Stage3-vs-Stage4 |
9.036200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.13399989188201E-10 |
| Normal-vs-AfricanAmerican |
4.992500E-04 |
| Normal-vs-Asian |
1.04930000000003E-06 |
| Caucasian-vs-AfricanAmerican |
9.851600E-02 |
| Caucasian-vs-Asian |
3.675800E-02 |
| AfricanAmerican-vs-Asian |
4.984400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.78579961718617E-10 |
| Normal-vs-Female |
1.362190E-04 |
| Male-vs-Female |
2.739600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.8780000000056E-05 |
| Normal-vs-Extreme_Weight |
1.82710002682995E-09 |
| Normal-vs-Obese |
2.40440000000008E-05 |
| Normal-vs-Extreme_Obese |
4.472200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.609400E-01 |
| Normal_Weight-vs-Obese |
5.972800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.323000E-01 |
| Extreme_Weight-vs-Obese |
1.784620E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.912200E-02 |
| Obese-vs-Extreme_Obese |
2.944600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.723400E-03 |
| Normal-vs-Age(41-60Yrs) |
2.33660000004132E-06 |
| Normal-vs-Age(61-80Yrs) |
9.14539999286035E-10 |
| Normal-vs-Age(81-100Yrs) |
4.15779999984878E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.511000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.016400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.263600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.664200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.979500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.654600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.19989999445036E-08 |
| Normal-VS-Type2 PRCC |
1.4623000033076E-08 |
| Normal-VS-KIRP CIMP |
7.182900E-03 |
| Normal-VS-Unclassified PRCC |
1.282130E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.572000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.977770E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.004200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.572800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.745800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.831200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.43699996346669E-09 |
| Normal-vs-N1 |
5.38700000052295E-07 |
| Normal-vs-N2 |
3.56090000042109E-07 |
| N0-vs-N1 |
7.599400E-01 |
| N0-vs-N2 |
2.383900E-03 |
| N1-vs-N2 |
9.026200E-02 |
|
|
